The suit is part of a wave of cases, including suits against UnitedHealth and Cigna, challenging health insurers' denial of coverage for inpatient mental health and substance abuse treatment for mentally ill teenagers and young adults.
The complaint further alleges the defendants knew of the association between GLP-1 receptor agonists and the risk of developing severe gastrointestinal issues but ignored the association and failed to disclose the information they possessed.
The pharmacy benefit manager is accused of pressuring Iowa-based Osterhaus Pharmacy into paying "direct and indirect remuneration" for filling Medicare prescriptions.